Non-invasive treatment for Type I Complex Regional Pain Syndrome

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effectiveness of non-invasive neuromodulation combined with conventional care for patients suffering from Type I Complex Regional Pain Syndrome (CRPS). It is a randomized, triple-blind clinical trial involving 42 participants who will be divided into control and experimental groups. The study aims to assess pain relief and functional improvement at three different time points: before, during, and after the intervention. Statistical analyses will be conducted to evaluate the outcomes and determine the significance of the findings.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Meet the Budapest criteria for the clinical diagnosis of CRPS type I.
* Age between 18 and 65.
* Period between 0 and 6 months after the onset of the clinical picture.
* Have signed the informed consent of their own free will.

Exclusion Criteria:

* Have a diagnosis of CRPS type II.
* Present type I CRPS in more than one limb.
* Patients who have suffered a recurrence of CRPS type I.
* Pregnancy or plans for it during the study.
* Previous sympathectomy in the affected limb.

Where it's running

• Aníbal Báez Suárez
  Las Palmas de Gran Canaria, Palmas, Las, Spain Recruiting

Study contacts

• Principal investigator: Aníbal Báez-Suárez, PhD — University of Las Palmas de Gran Canaria
• Study coordinator: Aníbal Báez-Suárez, PhD
• Email: anibal.baez@ulpgc.es
• Phone: +34 652077692

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• NESA neuromodulation versus posterior tibial nerve stimulation for overactive bladder

  This project will try NESA non-invasive neuromodulation versus posterior tibial nerve stimulation to see which better reduces urgency, frequency, and leakage in adult women with overactive bladder.

  Recruiting University of Las Palmas de Gran Canaria · Valencia · NCT07019597

• Using blood markers to predict nerve invasion in pancreatic cancer

  This study is trying to see if certain blood markers can help predict nerve invasion in patients with pancreatic cancer to improve their treatment plans.

  Recruiting University of Las Palmas de Gran Canaria · Las Palmas de Gran Canaria, Las Palmas · NCT06747481

• Using non-invasive neuromodulation to help stroke recovery

  This study is testing whether a new non-invasive treatment using microcurrents can help stroke survivors improve their balance, reduce pain, and manage spasticity.

  Recruiting University of Las Palmas de Gran Canaria · Las Palmas de Gran Canaria, Las Palmas · NCT05853952

• Assessing the prevalence of Long COVID-19 in the Canary Islands

  This study is trying to find out how many people in the Canary Islands have Long COVID-19 symptoms that last for more than 12 weeks after their COVID-19 infection.

  Recruiting University of Las Palmas de Gran Canaria · Las Palmas de Gran Canaria, Las Palmas · NCT05228691

• Using the NXSignal Device to treat ACL injuries

  This study is testing if the NXSignal device can help people recover better from ACL injuries after surgery compared to a placebo or standard rehab.

  Recruiting University of Las Palmas de Gran Canaria · Las Palmas de Gran Canaria, Las Palmas · NCT05207943

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.